PolyNovo Limited (ASX: PNV) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
PolyNovo Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
PolyNovo Limited (ASX: PNV)
Latest News
Share Gainers
Here are the top 10 ASX 200 shares today
Share Gainers
Why Aussie Broadband, Kogan, Pilbara Minerals, and Polynovo shares are storming higher
Earnings Results
This beaten down ASX 200 stock just defied short sellers to surge 9%. Here's why
Share Market News
These are the 10 most shorted ASX shares
Share Market News
These are the 10 most shorted ASX shares
Share Market News
These are the 10 most shorted ASX shares
Share Market News
CSL, Telix and more: Key reporting dates for 10 ASX 200 healthcare stocks in August
Share Market News
These are the 10 most shorted ASX shares
Healthcare Shares
Macquarie predicts 86% upside for this ASX 200 healthcare stock
Share Gainers
Here are the top 10 ASX 200 shares today
Broker Notes
Top brokers name 3 ASX shares to buy today
Share Gainers
Why Boss Energy, DroneShield, Pilbara Minerals, and Polynovo shares are charging higher today
Frequently Asked Questions
-
The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was listed on the ASX on 26 November 1998 and is headquartered in Melbourne.
-
No, the company does not historically pay dividends.
PNV ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About PolyNovo Limited
PolyNovo Ltd (ASX: PNV) develops and commercialises innovative medical devices using its patented NovoSorb technology.
NovoSorb is a family of biocompatible polymers that are used in the treatment of burns and surgical wounds. They biodegrade into by-products that can be absorbed and excreted by the body. For example, its NovoSorb BTM (Biodegradable Temporising Matrix) can be used to temporarily close a wound and aid the body in generating new tissue.
PolyNovo’s products are sold across Australia and New Zealand, the United States, the United Kingdom, and Europe.
